Who
Wendy B. Young
Director
Company insider
Files Form 4 as: Director, Adial Pharmaceuticals; Director, Rapport Therapeutics.
In numbers
- Trades disclosed
- 10
- Buys
- 2
- Sells
- 0
- Bought
- $140K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 7 Nov 2024
- Last trade
- 17 Sep 2026
- Last filed
- 21 Sep 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Sep 2026filed 21 Sep 2026 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,666 at $0.00 | filing |
| 17 Sep 2026filed 21 Sep 2026 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,666 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | $100K36,378 at $2.75 | filing |
| 12 Jun 2026filed 16 Jun 2026 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | $100K36,378 at $2.75 | filing |
| 10 Jun 2026filed 10 Jun 2026 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,200 at $0.00 | filing |
| 10 Jun 2026filed 10 Jun 2026 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,200 at $0.00 | filing |
| 11 Sep 2025filed 11 Sep 2025 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Bought | $79K3,500 at $22.60 | filing |
| 17 Jun 2025filed 18 Jun 2025 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,925 at $0.00 | filing |
| 12 Mar 2025filed 13 Mar 2025 | RAPP Rapport TherapeuticsBiotechnology | SEC FORM 4 Bought | $61K6,000 at $10.21 | filing |
| 7 Nov 2024filed 7 Nov 2024 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,756 at $0.00 | filing |
News
Why Is Rapport Therapeutics Stock Trading Higher Today?RAPP · aol.com · 20 Oct 2026Rapport Therapeutics Rockets On Positive, But Mixed, Bipolar DataRAPP · investors.com · 20 Oct 2026Rapport Therapeutics (NASDAQ:RAPP) CEO Abraham Ceesay Sells 1,147 Shares of Company StockRAPP · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Wendy B. Young; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.